National Research Corporation Sued Over Seemingly Shady Stock Transaction
by Erin Shaak
Last Updated on May 8, 2018
Gennaro v. National Research Corporation et al.
Filed: November 15, 2017 ◆§ 4:17-cv-00441-JMG-MDN
National Research Corporation and five directors have been accused of approving a stock transaction that will force stockholders out of the value of their shares and award an overwhelming majority of voting rights to the company’s CEO.
National Research Corporation and five members of its board of directors have been accused of approving a stock transaction that will force stockholders out of the value of their shares and award an overwhelming majority of voting rights to the company’s CEO, Michael D. Hays.
The company allegedly announced it was planning to initiate a 1-for-1,764,560 reverse stock split of its Class B common stock, which would force all Class B stockholders except for Hays to cash out their shares for a “wholly inadequate” price. The transaction, according to the complaint, would effectively result in Hays controlling 92 percent of the voting rights in the company, despite only owning 33 percent of its economic interests.
The suit further argues that the defendants performed no financial analyses to determine the Class B stock value, which the suit claims is “egregiously improper and unfair.” The proposed transaction, according to the plaintiff, will cheat stockholders out of the future value of their shares in the company while “solidifying Hays’ iron grip” over its decisions.
Hair Relaxer Lawsuits
Women who developed ovarian or uterine cancer after using hair relaxers such as Dark & Lovely and Motions may now have an opportunity to take legal action.
Read more here: Hair Relaxer Cancer Lawsuits
How Do I Join a Class Action Lawsuit?
Did you know there's usually nothing you need to do to join, sign up for, or add your name to new class action lawsuits when they're initially filed?
Read more here: How Do I Join a Class Action Lawsuit?
Stay Current
Sign Up For
Our Newsletter
New cases and investigations, settlement deadlines, and news straight to your inbox.
Before commenting, please review our comment policy.